Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2008.105023v1, 2008; 10.1373/clinchem.2008.105023
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.105023v1
54/11/1815    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Wu, M.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Wu, M.-H.

Received on February 11, 2008
Accepted on August 18, 2008

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Abnormal Matrix Remodeling in Adolescents and Young Adults with Kawasaki Disease Late after Onset

Ming-Tai Lin 1, Shyh-Jye Chen 2, Yi-Lwun Ho 3, Kuo-Chin Huang 4, Chun-An Chen 1, Shuenn-Nan Chiu 1, Li-Chuan Sun 1, Wen-Jeng Lee 2, Hui-Chi Chen 5, Jou-Kou Wang 1, Mei-Hwan Wu 1*

1 Department of Pediatrics, National Taiwan University, Taipei, Taiwan
2 Department of Medical Imaging, National Taiwan University, Taipei, Taiwan
3 Department of Internal Medicine, National Taiwan University, Taipei, Taiwan
4 Department of Family Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
5 Department of Graduate Institute of Epidemiology, National Taiwan University, Taipei, Taiwan

* To whom correspondence should be addressed. E-mail: wumh{at}ntu.edu.tw.

BACKGROUND: Patients with a history of Kawasaki disease (KD), have been found to have pericoronary and myocardial fibrosis. Serum biomarkers of fibrosis may be sensitive indices for detection of these late cardiac complications in KD patients.

METHODS: We studied a cohort of 60 adolescents and young adults comprising 10 KD patients with persistent coronary artery lesions (CAL) occurring at a mean (SD) time of 14.5 (4.4) years after disease onset, 25 KD patients with no CAL after disease onset, and 25 healthy age-matched volunteers. We compared laboratory data from the patients and volunteers, including lipid profile, liver function, amino-terminal propeptide of type III procollagen (PIIINP), matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinase 1 (TIMP-1), and MMP-9:TIMP-1 ratios. Severity of CAL was determined on the basis of computer tomography determinations of the frequency of aneurysms and the extent of coronary stenosis/occlusion, thrombosis, and calcification.

RESULTS: Increased PIIINP and decreased MMP-9 and TIMP-1 concentrations and decreased MMP-9:TIMP-1 ratios were found not only in KD patients with persistent CAL but also in KD patients without CAL, although to a lesser extent in the latter group. In KD patients, the concentrations of PIIINP were positively associated with the severity of coronary stenosis/occlusion (r = 0.72, P = 0.011) and with the extent of coronary thrombus (r = 0.64, P = 0.014). The concentrations of high-sensitivity C-reactive protein, however, did not differ across groups.

CONCLUSIONS: Our results demonstrate alterations in extracellular matrix biomarkers in KD patients, suggesting enhanced collagen synthesis and ameliorated degradation in adolescents and young adults late after the onset of KD. We also observed an association between the concentrations of PIIINP and the extent of coronary stenosis/occlusion or thrombosis in KD patients, a finding that needs confirmation in further studies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.